India Glycols Limited Logo

India Glycols Limited

INDIAGLYCO.NS

(2.5)
Stock Price

1.216,15 INR

3.13% ROA

11.86% ROE

17.47x PER

Market Cap.

27.978.359.475,00 INR

56.34% DER

0.83% Yield

5.73% NPM

India Glycols Limited Stock Analysis

India Glycols Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

India Glycols Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

4 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

5 ROE

The stock's ROE falls within an average range (14.38%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

6 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (18.312), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

7 ROA

The stock's ROA (0%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

India Glycols Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

India Glycols Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

India Glycols Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

India Glycols Limited Revenue
Year Revenue Growth
2005 7.112.768.000
2006 8.831.328.000 19.46%
2007 13.439.328.000 34.29%
2008 10.212.662.000 -31.59%
2009 11.978.600.000 14.74%
2010 19.525.515.000 38.65%
2011 27.071.215.000 27.87%
2012 34.225.642.000 20.9%
2013 29.765.720.000 -14.98%
2014 25.794.978.000 -15.39%
2015 23.257.655.000 -10.91%
2016 24.995.627.000 6.95%
2017 30.097.474.000 16.95%
2018 32.868.707.000 8.43%
2019 34.196.079.000 3.88%
2020 22.481.917.000 -52.1%
2021 28.132.772.000 20.09%
2022 26.508.600.000 -6.13%
2023 30.984.000.000 14.44%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

India Glycols Limited Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

India Glycols Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 590.361.000 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 330.111.000 100%
2016 620.847.000 46.83%
2017 231.426.000 -168.27%
2018 258.988.000 10.64%
2019 344.969.000 24.92%
2020 367.430.000 6.11%
2021 291.219.000 -26.17%
2022 475.466.000 38.75%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

India Glycols Limited EBITDA
Year EBITDA Growth
2005 1.228.759.000
2006 1.424.075.000 13.72%
2007 3.551.376.000 59.9%
2008 279.653.000 -1169.92%
2009 1.156.915.000 75.83%
2010 1.830.686.000 36.8%
2011 4.193.237.000 56.34%
2012 3.886.389.000 -7.9%
2013 4.000.343.000 2.85%
2014 1.784.016.000 -124.23%
2015 1.650.684.000 -8.08%
2016 2.065.104.000 20.07%
2017 3.162.659.000 34.7%
2018 4.111.890.000 23.09%
2019 3.872.624.000 -6.18%
2020 2.760.442.000 -40.29%
2021 2.867.702.000 3.74%
2022 3.307.900.000 13.31%
2023 4.284.400.000 22.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

India Glycols Limited Gross Profit
Year Gross Profit Growth
2005 3.022.603.000
2006 3.584.382.000 15.67%
2007 7.328.192.000 51.09%
2008 3.628.017.000 -101.99%
2009 4.368.618.000 16.95%
2010 19.628.297.000 77.74%
2011 6.439.677.000 -204.8%
2012 11.599.655.000 44.48%
2013 8.973.332.000 -29.27%
2014 8.198.957.000 -9.44%
2015 8.588.492.000 4.54%
2016 8.947.603.000 4.01%
2017 9.409.896.000 4.91%
2018 11.255.385.000 16.4%
2019 10.329.141.000 -8.97%
2020 7.057.360.000 -46.36%
2021 8.451.264.000 16.49%
2022 10.685.500.000 20.91%
2023 7.779.600.000 -37.35%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

India Glycols Limited Net Profit
Year Net Profit Growth
2005 585.771.000
2006 410.561.000 -42.68%
2007 1.785.385.000 77%
2008 -1.090.816.000 263.67%
2009 60.111.000 1914.67%
2010 -149.455.000 140.22%
2011 674.063.000 122.17%
2012 955.287.000 29.44%
2013 -1.613.579.000 159.2%
2014 -886.449.000 -82.03%
2015 -491.249.000 -80.45%
2016 350.440.000 240.18%
2017 965.272.000 63.7%
2018 1.326.141.000 27.21%
2019 1.146.557.000 -15.66%
2020 1.316.071.000 12.88%
2021 3.398.510.000 61.28%
2022 1.250.800.000 -171.71%
2023 1.520.400.000 17.73%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

India Glycols Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 21
2006 15 -50%
2007 64 78.13%
2008 -39 264.1%
2009 2 2050%
2010 -5 140%
2011 24 120.83%
2012 32 25%
2013 -52 161.54%
2014 -29 -85.71%
2015 -16 -86.67%
2016 11 236.36%
2017 31 64.52%
2018 43 26.19%
2019 37 -13.51%
2020 43 11.9%
2021 110 61.47%
2022 46 -142.22%
2023 49 8.16%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

India Glycols Limited Free Cashflow
Year Free Cashflow Growth
2005 -981.730.000
2006 -201.083.000 -388.22%
2007 -550.148.000 63.45%
2008 -3.380.104.000 83.72%
2009 -1.365.334.000 -147.57%
2010 -1.154.081.000 -18.3%
2011 -395.384.000 -191.89%
2012 6.488.474.000 106.09%
2013 -3.488.473.000 286%
2014 -2.422.023.000 -44.03%
2015 11.313.624.000 121.41%
2016 2.595.874.000 -335.83%
2017 3.722.241.000 30.26%
2018 78.954.000 -4614.44%
2019 1.882.761.000 95.81%
2020 -115.543.000 1729.49%
2021 -2.638.885.000 95.62%
2022 -1.130.600.000 -133.41%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

India Glycols Limited Operating Cashflow
Year Operating Cashflow Growth
2005 905.164.000
2006 1.874.241.000 51.71%
2007 1.440.822.000 -30.08%
2008 34.348.000 -4094.78%
2009 -171.886.000 119.98%
2010 -349.461.000 50.81%
2011 752.860.000 146.42%
2012 8.171.964.000 90.79%
2013 -2.338.704.000 449.42%
2014 -1.710.290.000 -36.74%
2015 12.383.918.000 113.81%
2016 3.020.708.000 -309.97%
2017 5.017.375.000 39.8%
2018 1.470.717.000 -241.15%
2019 3.432.591.000 57.15%
2020 1.373.287.000 -149.95%
2021 1.160.354.000 -18.35%
2022 3.257.100.000 64.37%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

India Glycols Limited Capital Expenditure
Year Capital Expenditure Growth
2005 1.886.894.000
2006 2.075.324.000 9.08%
2007 1.990.970.000 -4.24%
2008 3.414.452.000 41.69%
2009 1.193.448.000 -186.1%
2010 804.620.000 -48.32%
2011 1.148.244.000 29.93%
2012 1.683.490.000 31.79%
2013 1.149.769.000 -46.42%
2014 711.733.000 -61.54%
2015 1.070.294.000 33.5%
2016 424.834.000 -151.93%
2017 1.295.134.000 67.2%
2018 1.391.763.000 6.94%
2019 1.549.830.000 10.2%
2020 1.488.830.000 -4.1%
2021 3.799.239.000 60.81%
2022 4.387.700.000 13.41%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

India Glycols Limited Equity
Year Equity Growth
2005 2.873.719.000
2006 3.171.075.000 9.38%
2007 4.926.473.000 35.63%
2008 3.722.034.000 -32.36%
2009 3.854.234.000 3.43%
2010 3.842.878.000 -0.3%
2011 4.418.184.000 13.02%
2012 5.358.162.000 17.54%
2013 3.724.536.000 -43.86%
2014 2.970.523.000 -25.38%
2015 2.544.104.000 -16.76%
2016 7.523.306.000 66.18%
2017 8.451.449.000 10.98%
2018 9.626.272.000 12.2%
2019 10.338.660.000 6.89%
2020 11.685.231.000 11.52%
2021 17.724.223.000 34.07%
2022 19.014.200.000 6.78%
2023 19.667.800.000 3.32%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

India Glycols Limited Assets
Year Assets Growth
2005 9.830.485.000
2006 11.989.935.000 18.01%
2007 14.582.761.000 17.78%
2008 17.862.590.000 18.36%
2009 20.710.870.000 13.75%
2010 24.157.760.000 14.27%
2011 31.144.731.000 22.43%
2012 31.178.361.000 0.11%
2013 32.428.593.000 3.86%
2014 31.544.142.000 -2.8%
2015 29.965.375.000 -5.27%
2016 34.922.506.000 14.19%
2017 34.214.922.000 -2.07%
2018 37.843.234.000 9.59%
2019 40.862.334.000 7.39%
2020 41.192.407.000 0.8%
2021 46.306.684.000 11.04%
2022 48.583.300.000 4.69%
2023 51.191.600.000 5.1%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

India Glycols Limited Liabilities
Year Liabilities Growth
2005 6.956.766.000
2006 8.818.860.000 21.11%
2007 9.649.138.000 8.6%
2008 14.138.950.000 31.75%
2009 16.855.223.000 16.12%
2010 20.314.882.000 17.03%
2011 26.726.547.000 23.99%
2012 25.820.199.000 -3.51%
2013 28.704.057.000 10.05%
2014 28.573.619.000 -0.46%
2015 27.421.271.000 -4.2%
2016 27.399.200.000 -0.08%
2017 25.763.473.000 -6.35%
2018 28.216.962.000 8.7%
2019 30.523.674.000 7.56%
2020 29.507.176.000 -3.44%
2021 28.582.461.000 -3.24%
2022 29.569.100.000 3.34%
2023 31.523.800.000 6.2%

India Glycols Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
851.14
Net Income per Share
51.71
Price to Earning Ratio
17.47x
Price To Sales Ratio
1.06x
POCF Ratio
16.53
PFCF Ratio
-65.54
Price to Book Ratio
1.42
EV to Sales
1.48
EV Over EBITDA
9.89
EV to Operating CashFlow
23.05
EV to FreeCashFlow
-91.43
Earnings Yield
0.06
FreeCashFlow Yield
-0.02
Market Cap
27,98 Bil.
Enterprise Value
39,03 Bil.
Graham Number
859.5
Graham NetNet
-667.87

Income Statement Metrics

Net Income per Share
51.71
Income Quality
0.95
ROE
0.17
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.8
EBT Per Ebit
0.68
Ebit per Revenue
0.11
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.33
Operating Profit Margin
0.11
Pretax Profit Margin
0.07
Net Profit Margin
0.06

Dividends

Dividend Yield
0.01
Dividend Yield %
0.83
Payout Ratio
0.13
Dividend Per Share
7.5

Operating Metrics

Operating Cashflow per Share
54.66
Free CashFlow per Share
-13.78
Capex to Operating CashFlow
-1.25
Capex to Revenue
-0.08
Capex to Depreciation
-4.95
Return on Invested Capital
0.08
Return on Tangible Assets
0.03
Days Sales Outstanding
73.72
Days Payables Outstanding
179.62
Days of Inventory on Hand
183.93
Receivables Turnover
4.95
Payables Turnover
2.03
Inventory Turnover
1.98
Capex per Share
-68.44

Balance Sheet

Cash per Share
82,60
Book Value per Share
634,90
Tangible Book Value per Share
634.33
Shareholders Equity per Share
634.9
Interest Debt per Share
393.32
Debt to Equity
0.56
Debt to Assets
0.22
Net Debt to EBITDA
2.8
Current Ratio
0.9
Tangible Asset Value
19,65 Bil.
Net Current Asset Value
-13,31 Bil.
Invested Capital
0.56
Working Capital
-2,09 Bil.
Intangibles to Total Assets
0
Average Receivables
2,66 Bil.
Average Payables
4,18 Bil.
Average Inventory
4281750000
Debt to Market Cap
0.4

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

India Glycols Limited Dividends
Year Dividends Growth
2005 3
2006 3 0%
2007 3 0%
2008 4 25%
2009 1 -300%
2010 2 0%
2011 2 0%
2012 3 66.67%
2013 6 50%
2014 1 -500%
2017 1 0%
2018 4 75%
2019 6 33.33%
2020 6 0%
2021 6 0%
2022 8 14.29%
2023 8 0%

India Glycols Limited Profile

About India Glycols Limited

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triethylene glycols; polyethylene glycols; fatty alcohol, acid, and amine ethoxylates; alkyl phenol ethoxylates; castor/natural oil ethoxylates; and ethoxylated and propoxylated co-polymers. The company also provides polysorbates; glycol ethers and acetates; brake fluids and anti-freeze coolants; performance chemicals; natural gums, including guar gums and other hydrocolloid products; extra neutral alcohols/rectified spirits; Indian-made foreign liquor; and alcohol-based hand sanitizers. In addition, it offers natural active pharmaceutical ingredients, standardized botanical and herbal extracts, and spice extracts; and industrial gases, such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as IGL Steri-gas ethylene oxide and carbon dioxide gas mixtures. The company also exports its products. It serves agrochemical, automotive, detergent, healthcare and food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, textile, and other industries. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.

CEO
Mr. Rupark Sarswat
Employee
1.284
Address
Plot No. 2-B
Noida, 201304

India Glycols Limited Executives & BODs

India Glycols Limited Executives & BODs
# Name Age
1 Mr. Sudhir Agarwal
President Operations
70
2 Prof. Rakesh Kumar Khandal
President of R&D and Business Development
70
3 Mr. Ankur Jain
Head of Legal, Compliance Officer & Company Secretary
70
4 Mr. Rakesh Kumar
Chief Human Resources Officer
70
5 Mr. Uma Shankar Bhartia
Chairman & MD
70
6 Mr. Rupark Sarswat
Chief Executive Officer
70
7 Mr. Anand Singhal
Chief Financial Officer
70
8 Ms. Pragya Bhartia Barwale
Additional Whole Time Director
70
9 Mr. Madhup Misra
Head of Account & Admin
70
10 Mr. Rajesh Marwaha
Head of Marketing
70

India Glycols Limited Competitors